Delayed
Japan Exchange
11:30:00 05/06/2024 am IST
5-day change
1st Jan Change
18,925
JPY
-1.12%
+1.56%
+7.38%
HOYA : Presentation for the three months ended Dec.31,2020
January 28, 2021 at 10:06 am IST
FY20Q3
F i n a n c i a l R e s u l t s
January 28, 2021 Earnings Conference
7 7 4 1 . T [ A D R : H O C P Y U S ]
H O Y A C O R P O R A T I O N
© 2021 HOYA CORPORATION All Rights Reserved
Financial Results [Ryo Hirooka, CFO]
IT Business Overview
Life Care Business Overview
Summary
Q&A
© 2021 HOYA CORPORATION All Rights Reserved
2
Financial Overview
(¥bn)
Q3 FY19
Q3 FY20
YoY
YoY(%)
Revenue
146.5
146.9
+0.4
+0%
Pretax Profit
38.3
45.8
+7.5
+20%
Net Profit
29.7
36.9
+7.3
+25%
cf. Profit from
ordinary operating
38.3
46.1
+7.9
+21%
activities*
Recovery trend from COVID-19 continued, with double-digit profit growth and record profits.
© 2021 HOYA CORPORATION All Rights Reserved
3
Constant Currency Basis (CCB)
(¥bn)
Previous
Current
FX Impact
YoY
YoY(%)
Rate (A)
Rate (B)
Revenue
149.4
146.9
-2.5
+2.9
+2%
Pretax Profit
46.8
45.8
-1.0
+8.5
+22%
Net Profit
37.9
36.9
-1.0
+8.2
+28%
Average Rates
(A)Q3 FY19
(B)Q3 FY20
Variance
US$
¥109.33
¥104.00
+4.9%
EURO
¥121.53
¥124.49
-2.4%
BAHT
¥3.62
¥3.41
+5.7%
© 2021 HOYA CORPORATION All Rights Reserved
4
This is an excerpt of the original content. To continue reading it, access the original document here .
Attachments
Original document
Permalink
Disclaimer
Hoya Corporation published this content on 28 January 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 28 January 2021 04:35:03 UTC .
Hoya Corporation Announces Dividend for the Year Ending March 31, 2024, Payable on June 10, 2024
24/05
CI
HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ-EYE Ltd. Announces Their Intention to Form a Distribution Partnership for the U.S Market
17/05
CI
HOYA Corporation announces an Equity Buyback for 3,000,000 shares, representing 0.86% for ¥50,000 million.
15/05
CI
HOYA Corporation Revises Year-End Dividend Forecast for the Fiscal Year Ended March 31, 2024
15/05
CI
HOYA Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025
15/05
CI
HOYA Corporation authorizes a Buyback Plan.
15/05
CI
Cairn India Holdings Limited agreed to acquire additional 46.57% stake in AvanStrate Inc. from HOYA Corporation for ¥12.2 billion.
10/05
CI
Japanese Shares Lead Asia Rally, Take Cue from Wall Street
24/04
MT
Hoya Restores Most of Production, Ordering Systems After IT System Failure
24/04
MT
Hoya Flags IT System Failure; Stock Falls 3%
05/04
MT
Japanese lens maker Hoya halts production after cyberattack
04/04
RE
Japan to Extend Subsidy of up to 150 Billion Yen to Kioxia Holdings, Western Digital Plants
07/02
MT
UK Oil & Gas Says Pinarova-1 Project Lacks Commercial Hydrocarbon Flow, Ends Testing Activities
02/02
MT
UK Oil & Gas shares sink after Pinarova-1 testing setback
02/02
AN
UK Oil & Gas notes Pinarova-1 progress in Turkey
11/01
AN
UK Oil & Gas jumps as recommences operations at Pinarova-1
03/01
AN
88 Energy expands Texas footprint with acquisitions
15/12
AN
Vivid Seats Says Secondary Stock Offering Has Closed, Buys Back 2 Million Shares
13/12
MT
HOYA Corporation acquired the remaining 49% stake in Wassenburg Medical B.V.
22/11
CI
Poolbeg hails approval; EDX links with Thermo Fisher
21/11
AN
UK Oil & Gas to Resume Testing at Pinarova JV in Turkey After Receiving Perforating Guns
21/11
MT
Hoya Corporation Announces Interim Dividend for the Six Months Ended September 30, 2023
31/23/31
CI
Hoya Corp. ends 50 Billion Yen Buy-Back Program; Shares Fall Over 3%
26/23/26
MT
Tranche Update on HOYA Corporation's Equity Buyback Plan announced on July 31, 2023.
25/23/25
CI
China Outlook, Global Tensions Churn Asian Stock Markets
24/23/24
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Hoya Corporation specialises in the manufacture and commercialisation of optical products. Net sales break down by business segment as follows:
- health (66%): manufacturing of health care products (75.4% of sales; eyeglass lenses and contact lenses) and medical products (24.6%; endoscopes, medical accessories, intraocular lenses, artificial bones and metal implants for orthopedics);
- information technology (33.1%): manufacturing of electronic products (78.2% of sales; photomasks for semiconductors, masks and devices for LCD screens and hard disks) and imaging products (21.8%; optical lenses, optical glasses and laser equipment);
- other (0.9%).
Net sales are distributed geographically as follows: Japan (28.9%), China (8.2%), Asia (24.7%), Europe (19.3%), the United States (15.1%), the Americas (2.4%) and others (1.4%).
More about the company
Last Close Price
18,925
JPY
Average target price
21,336
JPY
Spread / Average Target
+12.74%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1